Nicholas Investment Partners, LP Vera Therapeutics, Inc. Transaction History
Nicholas Investment Partners, LP
- $912 Million
- Q4 2024
A detailed history of Nicholas Investment Partners, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 106,805 shares of VERA stock, worth $2.99 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
106,805
Previous 71,559
49.25%
Holding current value
$2.99 Million
Previous $3.16 Million
42.82%
% of portfolio
0.5%
Previous 0.35%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$157 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$123 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$93.4 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$82.9 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$82.6 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $757M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...